The Division of Hematology and Oncology at Vanderbilt University Medical Center is seeking board-certified/board eligible hematologist-oncologists for melanoma, lung cancer, and genitourinary (GU) cancers. The individuals selected will be academically oriented and appointed to the full-time faculty as either an Assistant or Associate Professor in the School of Medicine at Vanderbilt University.
Seeking Melanoma, Lung Cancer, or GU Cancer Faculty
The successful candidate(s) will have experience in caring for patients with melanoma, lung cancer, or GU cancer, with interest and/or experience conducting clinical trials in these diseases.
Junior faculty and new fellowship graduates will join the faculty and receive dedicated mentoring in clinical research, and experienced clinical researchers (Associate Professor level) will have opportunities to mentor junior faculty and fellows in these areas.
The selected individual(s) will work closely with the Chief of the Division of Hematology/Oncology and disease group section leader to further develop a clinical trial portfolio, and conduct clinical and translational research. For melanoma candidates, there is potential to rise to melanoma group section leader. For GU candidates, there is a particular opportunity for leadership in urothelial cell carcinoma research and clinical care.
The ideal candidate(s) will be a dedicated clinician, clinical researcher, who would enjoy participating in a robust training program of residents and fellows, and growing to a top-notch research program in melanoma, lung cancer, or GU cancer.
Competitive salary with benefits including, but not limited to medical, dental, vision, and life insurance; retirement contribution; tuition benefit for college-bound dependents; professional development funds; and relocation allowance.
If you are interested in joining this burgeoning Heme-Onc Division, please send your CV to Sharee Burkeen at email@example.com.